Profil
Vera Goossens worked as a Director-Lab Services at AlgoNomics NV and as a Principal at Fujirebio Europe NV from 2002 to 2007.
She received a doctorate degree from Ghent University in 1996.
Anciens postes connus de Vera Goossens
Sociétés | Poste | Fin |
---|---|---|
Fujirebio Europe NV
Fujirebio Europe NV Medical SpecialtiesHealth Technology Fujirebio Europe NV develops and markets diagnostic products to improve therapy management and patient health. It focuses on molecular diagnostics and multiparameter testing. The firm also provides LUMIPULSE G1200, an automated chemiluminescent enzyme immunoassay system; LUMIPULSE G600 II, an automated benchtop CLEIA system, routine and novel markers for the oncology sector. The company was founded in 1985 by Philippe Leboulch and is headquartered in Ghent, Belgium. | Corporate Officer/Principal | 01/01/2007 |
AlgoNomics NV
AlgoNomics NV Pharmaceuticals: MajorHealth Technology AlgoNomics NV provided integrated immunogenicity services for the biopharmaceutical industry. The company's products included Epibase, Epibase-IV, and Tripole. It was founded by Philippe Stas and Ignace Lasters in 1999 and was headquartered in Gent, Belgium. | Corporate Officer/Principal | - |
Formation de Vera Goossens
Ghent University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 2 |
---|---|
AlgoNomics NV
AlgoNomics NV Pharmaceuticals: MajorHealth Technology AlgoNomics NV provided integrated immunogenicity services for the biopharmaceutical industry. The company's products included Epibase, Epibase-IV, and Tripole. It was founded by Philippe Stas and Ignace Lasters in 1999 and was headquartered in Gent, Belgium. | Health Technology |
Fujirebio Europe NV
Fujirebio Europe NV Medical SpecialtiesHealth Technology Fujirebio Europe NV develops and markets diagnostic products to improve therapy management and patient health. It focuses on molecular diagnostics and multiparameter testing. The firm also provides LUMIPULSE G1200, an automated chemiluminescent enzyme immunoassay system; LUMIPULSE G600 II, an automated benchtop CLEIA system, routine and novel markers for the oncology sector. The company was founded in 1985 by Philippe Leboulch and is headquartered in Ghent, Belgium. | Health Technology |